Global Radiopharmaceuticals in Nuclear Medicine Market Insights, Forecast to 2025

Publisher Name :
Date: 25-Apr-2019
No. of pages: 124
Inquire Before Buying

The global Radiopharmaceuticals in Nuclear Medicine market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Radiopharmaceuticals in Nuclear Medicine market based on company, product type, end user and key regions.

This report studies the global market size of Radiopharmaceuticals in Nuclear Medicine in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Radiopharmaceuticals in Nuclear Medicine in these regions.

This research report categorizes the global Radiopharmaceuticals in Nuclear Medicine market by top players/brands, region, type and end user. This report also studies the global Radiopharmaceuticals in Nuclear Medicine market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:

- Bracco Imaging S.P.A.

- Cambridge Isotope Laboratories, Inc.

- Cardinal Health, Inc.

- Covidien, Plc

- Eczacibasi-Monrol

- Fujifilm Holdings Corporation

- GE Healthcare (Subsidiary Of General Electric Company)

- IBA Group

- Isotec, Inc. (Sigma-Aldrich)

- Lantheus Medical Imaging, Inc.

- Nordion, Inc.

- Ntp Radioisotopes (Pty), Ltd.

- Siemens Healthcare (Subsidiary Of Siemens AG)

- Taiyo Nippon Sanso Corporation

- Urenco Limited

- Rotem Industries, Ltd., Inc.

- Australian Nuclear Association And Technology Organization (ANSTO)

- Board of Radiation And Isotope Technology (BRIT)

- Institute of Atomic Energy Polatom Radioisotope Centre

- Institute of Isotopes Co., Ltd.

- Institute Of Radioelement (IRE)

Market size by Product

- Diagnostic Radiopharmaceuticals

- Therapy Radiopharmaceuticals

- Enriched Stable Isotopes

Market size by End User

- Diagnostic Application

- Therapeutic Application

- Research

- Pharmaceutical

- Other

Market size by Region

- North America

- - United States

- - Canada

- - Mexico

- Asia-Pacific

- - China

- - India

- - Japan

- - South Korea

- - Australia

- - Indonesia

- - Singapore

- - Malaysia

- - Philippines

- - Thailand

- - Vietnam

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Spain

- - Russia

- Central & South America

- - Brazil

- - Rest of Central & South America

- Middle East & Africa

- - GCC Countries

- - Turkey

- - Egypt

- - South Africa

The study objectives of this report are:

- To study and analyze the global Radiopharmaceuticals in Nuclear Medicine market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.

- To understand the structure of Radiopharmaceuticals in Nuclear Medicine market by identifying its various subsegments.

- To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

- Focuses on the key global Radiopharmaceuticals in Nuclear Medicine companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.

- To project the value and sales volume of Radiopharmaceuticals in Nuclear Medicine submarkets, with respect to key regions.

- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Radiopharmaceuticals in Nuclear Medicine are as follows:

- History Year: 2014-2018

- Base Year: 2018

- Estimated Year: 2019

- Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Radiopharmaceuticals in Nuclear Medicine market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Global Radiopharmaceuticals in Nuclear Medicine Market Insights, Forecast to 2025

Table of Contents
1 Study Coverage
1.1 Radiopharmaceuticals in Nuclear Medicine Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Radiopharmaceuticals in Nuclear Medicine Market Size Growth Rate by Product
1.4.2 Diagnostic Radiopharmaceuticals
1.4.3 Therapy Radiopharmaceuticals
1.4.4 Enriched Stable Isotopes
1.5 Market by End User
1.5.1 Global Radiopharmaceuticals in Nuclear Medicine Market Size Growth Rate by End User
1.5.2 Diagnostic Application
1.5.3 Therapeutic Application
1.5.4 Research
1.5.5 Pharmaceutical
1.5.6 Other
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Radiopharmaceuticals in Nuclear Medicine Market Size
2.1.1 Global Radiopharmaceuticals in Nuclear Medicine Revenue 2014-2025
2.1.2 Global Radiopharmaceuticals in Nuclear Medicine Sales 2014-2025
2.2 Radiopharmaceuticals in Nuclear Medicine Growth Rate by Regions
2.2.1 Global Radiopharmaceuticals in Nuclear Medicine Sales by Regions
2.2.2 Global Radiopharmaceuticals in Nuclear Medicine Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Radiopharmaceuticals in Nuclear Medicine Sales by Manufacturers
3.1.1 Radiopharmaceuticals in Nuclear Medicine Sales by Manufacturers
3.1.2 Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Manufacturers
3.1.3 Global Radiopharmaceuticals in Nuclear Medicine Market Concentration Ratio (CR5 and HHI)
3.2 Radiopharmaceuticals in Nuclear Medicine Revenue by Manufacturers
3.2.1 Radiopharmaceuticals in Nuclear Medicine Revenue by Manufacturers (2014-2019)
3.2.2 Radiopharmaceuticals in Nuclear Medicine Revenue Share by Manufacturers (2014-2019)
3.3 Radiopharmaceuticals in Nuclear Medicine Price by Manufacturers
3.4 Radiopharmaceuticals in Nuclear Medicine Manufacturing Base Distribution, Product Types
3.4.1 Radiopharmaceuticals in Nuclear Medicine Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Radiopharmaceuticals in Nuclear Medicine Product Type
3.4.3 Date of International Manufacturers Enter into Radiopharmaceuticals in Nuclear Medicine Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global Radiopharmaceuticals in Nuclear Medicine Sales by Product
4.2 Global Radiopharmaceuticals in Nuclear Medicine Revenue by Product
4.3 Radiopharmaceuticals in Nuclear Medicine Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global Radiopharmaceuticals in Nuclear Medicine Breakdown Data by End User
6 North America
6.1 North America Radiopharmaceuticals in Nuclear Medicine by Countries
6.1.1 North America Radiopharmaceuticals in Nuclear Medicine Sales by Countries
6.1.2 North America Radiopharmaceuticals in Nuclear Medicine Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Radiopharmaceuticals in Nuclear Medicine by Product
6.3 North America Radiopharmaceuticals in Nuclear Medicine by End User
7 Europe
7.1 Europe Radiopharmaceuticals in Nuclear Medicine by Countries
7.1.1 Europe Radiopharmaceuticals in Nuclear Medicine Sales by Countries
7.1.2 Europe Radiopharmaceuticals in Nuclear Medicine Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Radiopharmaceuticals in Nuclear Medicine by Product
7.3 Europe Radiopharmaceuticals in Nuclear Medicine by End User
8 Asia Pacific
8.1 Asia Pacific Radiopharmaceuticals in Nuclear Medicine by Countries
8.1.1 Asia Pacific Radiopharmaceuticals in Nuclear Medicine Sales by Countries
8.1.2 Asia Pacific Radiopharmaceuticals in Nuclear Medicine Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Radiopharmaceuticals in Nuclear Medicine by Product
8.3 Asia Pacific Radiopharmaceuticals in Nuclear Medicine by End User
9 Central & South America
9.1 Central & South America Radiopharmaceuticals in Nuclear Medicine by Countries
9.1.1 Central & South America Radiopharmaceuticals in Nuclear Medicine Sales by Countries
9.1.2 Central & South America Radiopharmaceuticals in Nuclear Medicine Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Radiopharmaceuticals in Nuclear Medicine by Product
9.3 Central & South America Radiopharmaceuticals in Nuclear Medicine by End User
10 Middle East and Africa
10.1 Middle East and Africa Radiopharmaceuticals in Nuclear Medicine by Countries
10.1.1 Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Sales by Countries
10.1.2 Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Radiopharmaceuticals in Nuclear Medicine by Product
10.3 Middle East and Africa Radiopharmaceuticals in Nuclear Medicine by End User
11 Company Profiles
11.1 Bracco Imaging S.P.A.
11.1.1 Bracco Imaging S.P.A. Company Details
11.1.2 Company Business Overview
11.1.3 Bracco Imaging S.P.A. Radiopharmaceuticals in Nuclear Medicine Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Bracco Imaging S.P.A. Radiopharmaceuticals in Nuclear Medicine Products Offered
11.1.5 Bracco Imaging S.P.A. Recent Development
11.2 Cambridge Isotope Laboratories, Inc.
11.2.1 Cambridge Isotope Laboratories, Inc. Company Details
11.2.2 Company Business Overview
11.2.3 Cambridge Isotope Laboratories, Inc. Radiopharmaceuticals in Nuclear Medicine Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Cambridge Isotope Laboratories, Inc. Radiopharmaceuticals in Nuclear Medicine Products Offered
11.2.5 Cambridge Isotope Laboratories, Inc. Recent Development
11.3 Cardinal Health, Inc.
11.3.1 Cardinal Health, Inc. Company Details
11.3.2 Company Business Overview
11.3.3 Cardinal Health, Inc. Radiopharmaceuticals in Nuclear Medicine Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Cardinal Health, Inc. Radiopharmaceuticals in Nuclear Medicine Products Offered
11.3.5 Cardinal Health, Inc. Recent Development
11.4 Covidien, Plc
11.4.1 Covidien, Plc Company Details
11.4.2 Company Business Overview
11.4.3 Covidien, Plc Radiopharmaceuticals in Nuclear Medicine Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Covidien, Plc Radiopharmaceuticals in Nuclear Medicine Products Offered
11.4.5 Covidien, Plc Recent Development
11.5 Eczacibasi-Monrol
11.5.1 Eczacibasi-Monrol Company Details
11.5.2 Company Business Overview
11.5.3 Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medicine Sales, Revenue and Gross Margin (2014-2019)
11.5.4 Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medicine Products Offered
11.5.5 Eczacibasi-Monrol Recent Development
11.6 Fujifilm Holdings Corporation
11.6.1 Fujifilm Holdings Corporation Company Details
11.6.2 Company Business Overview
11.6.3 Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medicine Sales, Revenue and Gross Margin (2014-2019)
11.6.4 Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medicine Products Offered
11.6.5 Fujifilm Holdings Corporation Recent Development
11.7 GE Healthcare (Subsidiary Of General Electric Company)
11.7.1 GE Healthcare (Subsidiary Of General Electric Company) Company Details
11.7.2 Company Business Overview
11.7.3 GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medicine Sales, Revenue and Gross Margin (2014-2019)
11.7.4 GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medicine Products Offered
11.7.5 GE Healthcare (Subsidiary Of General Electric Company) Recent Development
11.8 IBA Group
11.8.1 IBA Group Company Details
11.8.2 Company Business Overview
11.8.3 IBA Group Radiopharmaceuticals in Nuclear Medicine Sales, Revenue and Gross Margin (2014-2019)
11.8.4 IBA Group Radiopharmaceuticals in Nuclear Medicine Products Offered
11.8.5 IBA Group Recent Development
11.9 Isotec, Inc. (Sigma-Aldrich)
11.9.1 Isotec, Inc. (Sigma-Aldrich) Company Details
11.9.2 Company Business Overview
11.9.3 Isotec, Inc. (Sigma-Aldrich) Radiopharmaceuticals in Nuclear Medicine Sales, Revenue and Gross Margin (2014-2019)
11.9.4 Isotec, Inc. (Sigma-Aldrich) Radiopharmaceuticals in Nuclear Medicine Products Offered
11.9.5 Isotec, Inc. (Sigma-Aldrich) Recent Development
11.10 Lantheus Medical Imaging, Inc.
11.10.1 Lantheus Medical Imaging, Inc. Company Details
11.10.2 Company Business Overview
11.10.3 Lantheus Medical Imaging, Inc. Radiopharmaceuticals in Nuclear Medicine Sales, Revenue and Gross Margin (2014-2019)
11.10.4 Lantheus Medical Imaging, Inc. Radiopharmaceuticals in Nuclear Medicine Products Offered
11.10.5 Lantheus Medical Imaging, Inc. Recent Development
11.11 Nordion, Inc.
11.12 Ntp Radioisotopes (Pty), Ltd.
11.13 Siemens Healthcare (Subsidiary Of Siemens AG)
11.14 Taiyo Nippon Sanso Corporation
11.15 Urenco Limited
11.16 Rotem Industries, Ltd., Inc.
11.17 Australian Nuclear Association And Technology Organization (ANSTO)
11.18 Board of Radiation And Isotope Technology (BRIT)
11.19 Institute of Atomic Energy Polatom Radioisotope Centre
11.20 Institute of Isotopes Co., Ltd.
11.21 Institute Of Radioelement (IRE)
12 Future Forecast
12.1 Radiopharmaceuticals in Nuclear Medicine Market Forecast by Regions
12.1.1 Global Radiopharmaceuticals in Nuclear Medicine Sales Forecast by Regions 2019-2025
12.1.2 Global Radiopharmaceuticals in Nuclear Medicine Revenue Forecast by Regions 2019-2025
12.2 Radiopharmaceuticals in Nuclear Medicine Market Forecast by Product
12.2.1 Global Radiopharmaceuticals in Nuclear Medicine Sales Forecast by Product 2019-2025
12.2.2 Global Radiopharmaceuticals in Nuclear Medicine Revenue Forecast by Product 2019-2025
12.3 Radiopharmaceuticals in Nuclear Medicine Market Forecast by End User
12.4 North America Radiopharmaceuticals in Nuclear Medicine Forecast
12.5 Europe Radiopharmaceuticals in Nuclear Medicine Forecast
12.6 Asia Pacific Radiopharmaceuticals in Nuclear Medicine Forecast
12.7 Central & South America Radiopharmaceuticals in Nuclear Medicine Forecast
12.8 Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Radiopharmaceuticals in Nuclear Medicine Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables and Figures
Figure Radiopharmaceuticals in Nuclear Medicine Product Picture
Table Radiopharmaceuticals in Nuclear Medicine Market Segments
Table Key Manufacturers Radiopharmaceuticals in Nuclear Medicine Covered
Table Global Radiopharmaceuticals in Nuclear Medicine Market Size Growth Rate by Product 2019-2025 (K Units) & (Million US$)
Figure Global Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Product 2014-2025
Figure Diagnostic Radiopharmaceuticals Product Picture
Table Major Manufacturers of Diagnostic Radiopharmaceuticals
Figure Therapy Radiopharmaceuticals Product Picture
Table Major Manufacturers of Therapy Radiopharmaceuticals
Figure Enriched Stable Isotopes Product Picture
Table Major Manufacturers of Enriched Stable Isotopes
Table Global Radiopharmaceuticals in Nuclear Medicine Market Size Growth Rate by End User 2019-2025 (K Units)
Figure Diagnostic Application
Figure Therapeutic Application
Figure Research
Figure Pharmaceutical
Figure Other
Figure Radiopharmaceuticals in Nuclear Medicine Report Years Considered
Figure Global Radiopharmaceuticals in Nuclear Medicine Market Size 2014-2025 (Million US$)
Figure Global Radiopharmaceuticals in Nuclear Medicine Sales 2014-2025 (K Units)
Table Global Radiopharmaceuticals in Nuclear Medicine Market Size by Regions 2014-2019 (K Units) & (Million US$)
Table Global Radiopharmaceuticals in Nuclear Medicine Sales by Regions 2014-2019 (K Units)
Table Global Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Regions 2014-2019
Figure Global Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Regions 2014-2019
Figure 2018 Global Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Regions
Table Global Radiopharmaceuticals in Nuclear Medicine Revenue by Regions 2014-2019 (Million US$)
Table Global Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Regions 2014-2019
Figure Global Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Regions 2014-2019
Figure 2018 Global Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Regions
Table Global Radiopharmaceuticals in Nuclear Medicine Sales by Manufacturers (2014-2019) (K Units)
Table Global Radiopharmaceuticals in Nuclear Medicine Sales Share by Manufacturers (2014-2019)
Figure Global Radiopharmaceuticals in Nuclear Medicine Sales Share by Manufacturers in 2018
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Radiopharmaceuticals in Nuclear Medicine Revenue by Manufacturers (2014-2019) (Million USD)
Table Radiopharmaceuticals in Nuclear Medicine Revenue Share by Manufacturers (2014-2019)
Figure Radiopharmaceuticals in Nuclear Medicine Value Share by Manufacturers in 2018
Table Key Manufacturers Radiopharmaceuticals in Nuclear Medicine Price (2014-2019) (USD/Unit)
Table Radiopharmaceuticals in Nuclear Medicine Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Radiopharmaceuticals in Nuclear Medicine Product Type
Table Date of International Manufacturers Enter into Radiopharmaceuticals in Nuclear Medicine Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Radiopharmaceuticals in Nuclear Medicine Sales by Product (2014-2019) (K Units)
Table Global Radiopharmaceuticals in Nuclear Medicine Sales Share by Product (2014-2019)
Figure Global Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Product (2014-2019)
Figure Global Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Product in 2018
Table Global Radiopharmaceuticals in Nuclear Medicine Revenue by Product (2014-2019) (Million US$)
Table Global Radiopharmaceuticals in Nuclear Medicine Revenue Share by Product (2014-2019)
Figure Global Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Product (2014-2019)
Figure Global Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Product in 2018
Table Radiopharmaceuticals in Nuclear Medicine Price by Product 2014-2019 (USD/Unit)
Table Global Radiopharmaceuticals in Nuclear Medicine Sales by End User (2014-2019) (K Units)
Table Global Radiopharmaceuticals in Nuclear Medicine Sales Share by End User (2014-2019)
Figure Global Sales Radiopharmaceuticals in Nuclear Medicine Market Share by End User (2014-2019)
Figure Global Sales Radiopharmaceuticals in Nuclear Medicine Market Share by End User in 2018
Figure North America Radiopharmaceuticals in Nuclear Medicine Sales Growth Rate 2014-2019 (K Units)
Figure North America Radiopharmaceuticals in Nuclear Medicine Revenue Growth Rate 2014-2019 (Million US$)
Table North America Radiopharmaceuticals in Nuclear Medicine Sales by Countries (2014-2019) (K Units)
Table North America Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Countries (2014-2019)
Figure 2018 North America Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Countries
Table North America Radiopharmaceuticals in Nuclear Medicine Revenue by Countries (2014-2019) (Million US$)
Table North America Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Countries (2014-2019)
Figure 2018 North America Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Countries
Figure United States Radiopharmaceuticals in Nuclear Medicine Sales Growth Rate (2014-2019) (K Units)
Figure United States Radiopharmaceuticals in Nuclear Medicine Revenue Growth Rate (2014-2019) (K Units)
Figure Canada Radiopharmaceuticals in Nuclear Medicine Sales Growth Rate (2014-2019) (K Units)
Figure Canada Radiopharmaceuticals in Nuclear Medicine Revenue Growth Rate (2014-2019) (Million US$)
Figure Mexico Radiopharmaceuticals in Nuclear Medicine Sales Growth Rate (2014-2019) (K Units)
Figure Mexico Radiopharmaceuticals in Nuclear Medicine Revenue Growth Rate (2014-2019) (Million US$)
Table North America Radiopharmaceuticals in Nuclear Medicine Sales by Product (2014-2019) (K Units)
Table North America Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Product (2014-2019)
Figure 2018 North America Radiopharmaceuticals in Nuclear Medicine Market Share by Product
Table North America Radiopharmaceuticals in Nuclear Medicine Sales by End User (2014-2019) (K Units)
Table North America Radiopharmaceuticals in Nuclear Medicine Sales Market Share by End User (2014-2019)
Figure 2018 North America Radiopharmaceuticals in Nuclear Medicine Market Share by End User
Figure Europe Radiopharmaceuticals in Nuclear Medicine Sales Growth Rate 2014-2019 (K Units)
Figure Europe Radiopharmaceuticals in Nuclear Medicine Revenue Growth Rate 2014-2019 (Million US$)
Table Europe Radiopharmaceuticals in Nuclear Medicine Sales by Countries (2014-2019) (K Units)
Table Europe Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Countries (2014-2019)
Figure 2018 Europe Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Countries
Table Europe Radiopharmaceuticals in Nuclear Medicine Revenue by Countries (2014-2019) (Million US$)
Table Europe Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Countries (2014-2019)
Figure 2018 Europe Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Countries
Figure Germany Radiopharmaceuticals in Nuclear Medicine Sales Growth Rate (2014-2019) (K Units)
Figure Germany Radiopharmaceuticals in Nuclear Medicine Revenue Growth Rate (2014-2019) (Million US$)
Figure France Radiopharmaceuticals in Nuclear Medicine Sales Growth Rate (2014-2019) (K Units)
Figure France Radiopharmaceuticals in Nuclear Medicine Revenue Growth Rate (2014-2019) (Million US$)
Figure UK Radiopharmaceuticals in Nuclear Medicine Sales Growth Rate (2014-2019) (K Units)
Figure UK Radiopharmaceuticals in Nuclear Medicine Revenue Growth Rate (2014-2019) (Million US$)
Figure Italy Radiopharmaceuticals in Nuclear Medicine Sales Growth Rate (2014-2019) (K Units)
Figure Italy Radiopharmaceuticals in Nuclear Medicine Revenue Growth Rate (2014-2019) (Million US$)
Figure Russia Radiopharmaceuticals in Nuclear Medicine Sales Growth Rate (2014-2019) (K Units)
Figure Russia Radiopharmaceuticals in Nuclear Medicine Revenue Growth Rate (2014-2019) (Million US$)
Table Europe Radiopharmaceuticals in Nuclear Medicine Sales by Product (2014-2019) (K Units)
Table Europe Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Product (2014-2019)
Figure 2018 Europe Radiopharmaceuticals in Nuclear Medicine Market Share by Product
Table Europe Radiopharmaceuticals in Nuclear Medicine Sales by End User (2014-2019) (K Units)
Table Europe Radiopharmaceuticals in Nuclear Medicine Sales Market Share by End User (2014-2019)
Figure 2018 Europe Radiopharmaceuticals in Nuclear Medicine Market Share by End User
Figure Asia Pacific Radiopharmaceuticals in Nuclear Medicine Sales Growth Rate 2014-2019 (K Units)
Figure Asia Pacific Radiopharmaceuticals in Nuclear Medicine Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific Radiopharmaceuticals in Nuclear Medicine Sales by Countries (2014-2019) (K Units)
Table Asia Pacific Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Countries
Table Asia Pacific Radiopharmaceuticals in Nuclear Medicine Revenue by Countries (2014-2019) (Million US$)
Table Asia Pacific Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Countries
Figure China Radiopharmaceuticals in Nuclear Medicine Sales Growth Rate (2014-2019) (K Units)
Figure China Radiopharmaceuticals in Nuclear Medicine Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan Radiopharmaceuticals in Nuclear Medicine Sales Growth Rate (2014-2019) (K Units)
Figure Japan Radiopharmaceuticals in Nuclear Medicine Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea Radiopharmaceuticals in Nuclear Medicine Sales Growth Rate (2014-2019) (K Units)
Figure Korea Radiopharmaceuticals in Nuclear Medicine Revenue Growth Rate (2014-2019) (Million US$)
Figure India Radiopharmaceuticals in Nuclear Medicine Sales Growth Rate (2014-2019) (K Units)
Figure India Radiopharmaceuticals in Nuclear Medicine Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia Radiopharmaceuticals in Nuclear Medicine Sales Growth Rate (2014-2019) (K Units)
Figure Australia Radiopharmaceuticals in Nuclear Medicine Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia Radiopharmaceuticals in Nuclear Medicine Sales Growth Rate (2014-2019) (K Units)
Figure Indonesia Radiopharmaceuticals in Nuclear Medicine Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia Radiopharmaceuticals in Nuclear Medicine Sales Growth Rate (2014-2019) (K Units)
Figure Malaysia Radiopharmaceuticals in Nuclear Medicine Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines Radiopharmaceuticals in Nuclear Medicine Sales Growth Rate (2014-2019) (K Units)
Figure Philippines Radiopharmaceuticals in Nuclear Medicine Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand Radiopharmaceuticals in Nuclear Medicine Sales Growth Rate (2014-2019) (K Units)
Figure Thailand Radiopharmaceuticals in Nuclear Medicine Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam Radiopharmaceuticals in Nuclear Medicine Sales Growth Rate (2014-2019) (K Units)
Figure Vietnam Radiopharmaceuticals in Nuclear Medicine Revenue Growth Rate (2014-2019) (Million US$)
Figure Singapore Radiopharmaceuticals in Nuclear Medicine Sales Growth Rate (2014-2019) (K Units)
Figure Singapore Radiopharmaceuticals in Nuclear Medicine Revenue Growth Rate (2014-2019) (Million US$)
Table Asia Pacific Radiopharmaceuticals in Nuclear Medicine Sales by Product (2014-2019) (K Units)
Table Asia Pacific Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Product (2014-2019)
Figure 2018 Asia Pacific Radiopharmaceuticals in Nuclear Medicine Market Share by Product
Table Asia Pacific Radiopharmaceuticals in Nuclear Medicine Sales by End User (2014-2019) (K Units)
Table Asia Pacific Radiopharmaceuticals in Nuclear Medicine Sales Market Share by End User (2014-2019)
Figure 2018 Asia Pacific Radiopharmaceuticals in Nuclear Medicine Market Share by End User
Figure Central & South America Radiopharmaceuticals in Nuclear Medicine Sales Growth Rate 2014-2019 (K Units)
Figure Central & South America Radiopharmaceuticals in Nuclear Medicine Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America Radiopharmaceuticals in Nuclear Medicine Sales by Countries (2014-2019) (K Units)
Table Central & South America Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Countries (2014-2019)
Figure 2018 Central & South America Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Countries
Table Central & South America Radiopharmaceuticals in Nuclear Medicine Revenue by Countries (2014-2019) (Million US$)
Table Central & South America Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Countries (2014-2019)
Figure 2018 Central & South America Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Countries
Figure Brazil Radiopharmaceuticals in Nuclear Medicine Sales Growth Rate (2014-2019) (K Units)
Figure Brazil Radiopharmaceuticals in Nuclear Medicine Revenue Growth Rate (2014-2019) (Million US$)
Figure Argentina Radiopharmaceuticals in Nuclear Medicine Sales Growth Rate (2014-2019) (K Units)
Figure Argentina Radiopharmaceuticals in Nuclear Medicine Revenue Growth Rate (2014-2019) (Million US$)
Table Central & South America Radiopharmaceuticals in Nuclear Medicine Sales by Product (2014-2019) (K Units)
Table Central & South America Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Product (2014-2019)
Figure 2018 Central & South America Radiopharmaceuticals in Nuclear Medicine Market Share by Product
Table Central & South America Radiopharmaceuticals in Nuclear Medicine Sales by End User (2014-2019) (K Units)
Table Central & South America Radiopharmaceuticals in Nuclear Medicine Sales Market Share by End User (2014-2019)
Figure 2018 Central & South America Radiopharmaceuticals in Nuclear Medicine Market Share by End User
Figure Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Sales Growth Rate 2014-2019 (K Units)
Figure Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Sales by Countries (2014-2019) (K Units)
Table Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Countries
Table Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Revenue by Countries (2014-2019) (Million US$)
Table Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Countries
Figure GCC Countries Radiopharmaceuticals in Nuclear Medicine Sales Growth Rate (2014-2019) (K Units)
Figure GCC Countries Radiopharmaceuticals in Nuclear Medicine Revenue Growth Rate (2014-2019) (Million US$)
Figure Turkey Radiopharmaceuticals in Nuclear Medicine Sales Growth Rate (2014-2019) (K Units)
Figure Turkey Radiopharmaceuticals in Nuclear Medicine Revenue Growth Rate (2014-2019) (Million US$)
Figure Egypt Radiopharmaceuticals in Nuclear Medicine Sales Growth Rate (2014-2019) (K Units)
Figure Egypt Radiopharmaceuticals in Nuclear Medicine Revenue Growth Rate (2014-2019) (Million US$)
Figure South Africa Radiopharmaceuticals in Nuclear Medicine Sales Growth Rate (2014-2019) (K Units)
Figure South Africa Radiopharmaceuticals in Nuclear Medicine Revenue Growth Rate (2014-2019) (Million US$)
Table Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Sales by Product (2014-2019) (K Units)
Table Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Product (2014-2019)
Figure 2018 Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Market Share by Product
Table Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Sales by End User (2014-2019) (K Units)
Table Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Sales Market Share by End User (2014-2019)
Figure 2018 Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Market Share by End User
Table Bracco Imaging S.P.A. Company Details
Table Bracco Imaging S.P.A. Radiopharmaceuticals in Nuclear Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Bracco Imaging S.P.A. Recent Development
Table Cambridge Isotope Laboratories, Inc. Company Details
Table Cambridge Isotope Laboratories, Inc. Radiopharmaceuticals in Nuclear Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Cambridge Isotope Laboratories, Inc. Recent Development
Table Cardinal Health, Inc. Company Details
Table Cardinal Health, Inc. Radiopharmaceuticals in Nuclear Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Cardinal Health, Inc. Recent Development
Table Covidien, Plc Company Details
Table Covidien, Plc Radiopharmaceuticals in Nuclear Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Covidien, Plc Recent Development
Table Eczacibasi-Monrol Company Details
Table Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Eczacibasi-Monrol Recent Development
Table Fujifilm Holdings Corporation Company Details
Table Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Fujifilm Holdings Corporation Recent Development
Table GE Healthcare (Subsidiary Of General Electric Company) Company Details
Table GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table GE Healthcare (Subsidiary Of General Electric Company) Recent Development
Table IBA Group Company Details
Table IBA Group Radiopharmaceuticals in Nuclear Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table IBA Group Recent Development
Table Isotec, Inc. (Sigma-Aldrich) Company Details
Table Isotec, Inc. (Sigma-Aldrich) Radiopharmaceuticals in Nuclear Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Isotec, Inc. (Sigma-Aldrich) Recent Development
Table Lantheus Medical Imaging, Inc. Company Details
Table Lantheus Medical Imaging, Inc. Radiopharmaceuticals in Nuclear Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Lantheus Medical Imaging, Inc. Recent Development
Table Nordion, Inc. Company Details
Table Ntp Radioisotopes (Pty), Ltd. Company Details
Table Siemens Healthcare (Subsidiary Of Siemens AG) Company Details
Table Taiyo Nippon Sanso Corporation Company Details
Table Urenco Limited Company Details
Table Rotem Industries, Ltd., Inc. Company Details
Table Australian Nuclear Association And Technology Organization (ANSTO) Company Details
Table Board of Radiation And Isotope Technology (BRIT) Company Details
Table Institute of Atomic Energy Polatom Radioisotope Centre Company Details
Table Institute of Isotopes Co., Ltd. Company Details
Table Institute Of Radioelement (IRE) Company Details
Table Global Radiopharmaceuticals in Nuclear Medicine Sales Forecast by Regions 2019-2025 (K Units)
Table Global Radiopharmaceuticals in Nuclear Medicine Sales Market Share Forecast by Regions 2019-2025
Table Global Radiopharmaceuticals in Nuclear Medicine Revenue Forecast by Regions 2019-2025 (Million US$)
Table Global Radiopharmaceuticals in Nuclear Medicine Revenue Market Share Forecast by Regions 2019-2025
Table Global Radiopharmaceuticals in Nuclear Medicine Sales Forecast by Product 2019-2025 (K Units)
Table Global Radiopharmaceuticals in Nuclear Medicine Sales Market Share Forecast by Product 2019-2025
Table Global Radiopharmaceuticals in Nuclear Medicine Revenue Forecast by Product 2019-2025 (Million US$)
Table Global Radiopharmaceuticals in Nuclear Medicine Revenue Market Share Forecast by Product 2019-2025
Table Global Radiopharmaceuticals in Nuclear Medicine Sales Forecast by End User 2019-2025 (K Units)
Table Global Radiopharmaceuticals in Nuclear Medicine Sales Market Share Forecast by End User 2019-2025
Figure North America Radiopharmaceuticals in Nuclear Medicine Sales Growth Rate Forecast (2019-2025) (K Units)
Figure North America Radiopharmaceuticals in Nuclear Medicine Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Europe Radiopharmaceuticals in Nuclear Medicine Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Europe Radiopharmaceuticals in Nuclear Medicine Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Asia Pacific Radiopharmaceuticals in Nuclear Medicine Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Asia Pacific Radiopharmaceuticals in Nuclear Medicine Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Central & South America Radiopharmaceuticals in Nuclear Medicine Sales
  • Global Infusion Bags Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
    Published: 22-Oct-2019        Price: US 3480 Onwards        Pages: 123
    Scope of the Report: The worldwide market for Infusion Bags is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Infusion Bags in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and applicati......
  • Global Baby Scales Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
    Published: 22-Oct-2019        Price: US 3480 Onwards        Pages: 101
    Scope of the Report: The worldwide market for Baby Scales is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Baby Scales in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.......
  • Global Absorbable Gelatin Sponge Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
    Published: 22-Oct-2019        Price: US 3480 Onwards        Pages: 104
    Scope of the Report: The worldwide market for Absorbable Gelatin Sponge is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Absorbable Gelatin Sponge in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, reg......
  • Global Blood Bank Information Systems Market Growth (Status and Outlook) 2019-2024
    Published: 22-Oct-2019        Price: US 3660 Onwards        Pages: 131
    According to this study, over the next five years the Blood Bank Information Systems market will register a 4.0% CAGR in terms of revenue, the global market size will reach US$ 438.1 million by 2024, from US$ 374.6 million in 2019. In particular, this report presents the global revenue market share of key companies in Blood Bank Information Systems business, shared in Chapter 3. This report presents a comprehensive overview, market shares and growth opportunities of Blood Bank Inf......
  • Global Bare Metal Stents Market Growth 2019-2024
    Published: 22-Oct-2019        Price: US 3660 Onwards        Pages: 135
    According to this study, over the next five years the Bare Metal Stents market will register a 3.6% CAGR in terms of revenue, the global market size will reach US$ 1366.6 million by 2024, from US$ 1188.3 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Bare Metal Stents business, shared in Chapter 3. This report presents a comprehensive overview, market shares, and growth opportunities of Bare Metal Stents market ......
  • Global Perfusion Bioreactor Market Growth 2019-2024
    Published: 22-Oct-2019        Price: US 3660 Onwards        Pages: 167
    According to this study, over the next five years the Perfusion Bioreactor market will register a 9.7% CAGR in terms of revenue, the global market size will reach US$ 820.9 million by 2024, from US$ 567.7 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Perfusion Bioreactor business, shared in Chapter 3. This report presents a comprehensive overview, market shares, and growth opportunities of Perfusion Bioreactor ......
  • Global Vascular Snare Market Growth 2019-2024
    Published: 22-Oct-2019        Price: US 3660 Onwards        Pages: 131
    According to this study, over the next five years the Vascular Snare market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Vascular Snare business, shared in Chapter 3. This report presents a comprehensive overview, market shares, and growth opportunities of Vascular Snare market by product type, a......
  • Global Blood Glucose Meters and Strips and Continuous Glucose Monitoring Market Growth 2019-2024
    Published: 22-Oct-2019        Price: US 3660 Onwards        Pages: 131
    According to this study, over the next five years the Blood Glucose Meters and Strips and Continuous Glucose Monitoring market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Blood Glucose Meters and Strips and Continuous Glucose Monitoring business, shared in Chapter 3. This report presents a compr......
  • Global Single-use Bioprocessing Sensors and Probes Market Growth 2019-2024
    Published: 22-Oct-2019        Price: US 3660 Onwards        Pages: 162
    According to this study, over the next five years the Single-use Bioprocessing Sensors and Probes market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Single-use Bioprocessing Sensors and Probes business, shared in Chapter 3. This report presents a comprehensive overview, market shares, and growth......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs